R2 Technology to distribute MRS' mammography reporting software

TriMed Staff | | Health Imaging | Screening
R2 Technology Inc. and Mammography Reporting System Inc. (MRS) have signed a three-year distribution agreement for the MRS Mammography Reporting System.

 MRS and R2 will continue development work to enhance interpretative workflow by integrating the computer-aided detection (CAD) display from R2's ImageChecker system with the MRS Mammography Reporting System. R2 also will receive distribution rights to the MRS software.

 R2 estimates that it has more than 1,000 systems installed worldwide to assist radiologists in the detection of breast cancer. The R2 ImageChecker CAD system is approved by the FDA for use in both film-based and digital mammography.

 The MRS Mammography Reporting System generates a radiologist's exam report and an automatically selected lay-language patient result letter. It also is designed to track problem cases, generate follow-up letters and provide medical audit and practice management statistical reports.

TriMed Staff

Related Content

FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise
Singing radiologist pens song to clear up confusion about breast cancer screening recs
AI loaded onto mammography systems can flag possible cancers in real time to speed workflows
Over half of eligible women skip their mammogram

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup